Cancer vaccines based on mRNA advance, despite US cuts

mRNA-based cancer vaccines continue to advance despite funding cuts within the US. During the American Society of Clinical Oncology meeting held in Chicago this month, more than 130 studies focused on these specific efforts were presented. These findings highlight the ongoing progress of mRNA technology in the fight against cancer, maintaining momentum in clinical research and development even as financial support from the United States has decreased for these critical medical initiatives.